Health sciences and preventative medicines firm PreveCeutical Medical Inc (CSE:PREV, OTCQB:PRVCF) says its previously announced stock split will take place on May 24 this year.
Shareholders have previously agreed the move, which will be on the basis of five new shares for each one existing (5:1).
As of today (Wednesday), shares have begun trading on the Canadian Securities Exchange on an ex-distribution basis.
Preveceutical develops innovative options for preventive and curative therapies utilising organic and nature identical products.
"We believe the stock split demonstrates the company's continued commitment to broaden its shareholder base and we anticipate that the stock split will make PreveCeutical's securities more accessible to investors and enhance liquidity for shareholders,” president and chairman Stephen Van Deventer said earlier this month.